4 results
SC 14D9/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Tender offer solicitation (amended)
8:14am
Black or African American.
“The success of 177Lu-PNT2002 in this trial demonstrates the value of treating patients with radioligand therapy
8-K
EX-99.2
PNT
POINT Biopharma Global Inc.
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
years 20 (74.1) Race, n (%) Black or African American 4 (14.8) White 23 (85.2) Country, n (%) Canada 12 (44.4) United States 15 (55.6) PSA
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
Two or More Races
- Prev
- 1
- Next